- Previous Close
0.034 - Open
0.030 - Bid 0.030 x --
- Ask 0.033 x --
- Day's Range
0.030 - 0.033 - 52 Week Range
0.024 - 0.120 - Volume
1,640,000 - Avg. Volume
3,724,602 - Market Cap (intraday)
61.064M - Beta (5Y Monthly) -0.25
- PE Ratio (TTM)
3.30 - EPS (TTM)
0.010 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
King International Investment Limited, an investment holding company, provides genetic testing and health data analysis services in the People's Republic of China and Hong Kong. The company operates through two segments, Healthcare Products and Services Business, and Money Lending Business. The company also engages in money lending activities. In addition, it provides corporate administrative and healthcare services. The company was formerly known as Life Healthcare Group Limited and changed its name to King International Investment Limited in December 2023. King International Investment Limited was incorporated in 2001 and is based in Central, Hong Kong.
www.kinginternational.hkRecent News: 0928.HK
View MorePerformance Overview: 0928.HK
Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0928.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0928.HK
View MoreValuation Measures
Market Cap
61.06M
Enterprise Value
66.23M
Trailing P/E
4.34
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.32
Price/Book (mrq)
0.23
Enterprise Value/Revenue
0.35
Enterprise Value/EBITDA
3.34
Financial Highlights
Profitability and Income Statement
Profit Margin
6.69%
Return on Assets (ttm)
2.67%
Return on Equity (ttm)
5.03%
Revenue (ttm)
187.44M
Net Income Avi to Common (ttm)
12.54M
Diluted EPS (ttm)
0.010
Balance Sheet and Cash Flow
Total Cash (mrq)
179k
Total Debt/Equity (mrq)
2.01%
Levered Free Cash Flow (ttm)
-33.44M